Seven entrepreneurs will embark on a two-year fellowship as the seventh cohort of Innovation Crossroads kicks off this month at ORNL. Representing a range of transformative energy technologies, Cohort 7 is a diverse class of innovators with promising new companies.
Early experiments at the Department of Energy’s Oak Ridge National Laboratory have revealed significant benefits to a dry battery manufacturing process. This eliminates the use of solvents and is more affordable, while showing promise for delivering a battery that is durable, less weighed down by inactive elements, and able to maintain a high capacity after use.
Scientist-inventors from ORNL will present seven new technologies during the Technology Innovation Showcase on Friday, July 14, from 8 a.m.–4 p.m. at the Joint Institute for Computational Sciences on ORNL’s campus.
ORNL scientists found that a small tweak created big performance improvements in a type of solid-state battery, a technology considered vital to broader electric vehicle adoption.
Having passed the midpoint of his career, physicist Mali Balasubramanian was part of a tight-knit team at a premier research facility for X-ray spectroscopy. But then another position opened, at ORNL— one that would take him in a new direction.
When reading the novel Jurassic Park as a teenager, Jerry Parks found the passages about gene sequencing and supercomputers fascinating, but never imagined he might someday pursue such futuristic-sounding science.
Marm Dixit, a Weinberg Distinguished Staff Fellow at ORNL has received the 2023 Rosalind Franklin Young Investigator Award.
Oak Ridge National Laboratory scientists exploring bioenergy plant genetics have made a surprising discovery: a protein domain that could lead to new COVID-19 treatments.
Andrew Ullman, Distinguished Staff Fellow at Oak Ridge National Laboratory, is using chemistry to devise a better battery
A team of scientists led by the Department of Energy’s Oak Ridge National Laboratory designed a molecule that disrupts the infection mechanism of the SARS-CoV-2 coronavirus and could be used to develop new treatments for COVID-19 and other viral diseases.